Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ABVC held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 221K | $215K | +9.3% | 1.526% | 0.00% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 191K | $185K | β | 1.315% | 0.00% |
| 3 | VANGUARD FIDUCIARY TRUST CO | 97K | $94K | β | 0.672% | 0.00% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 95K | $92K | -16.8% | 0.656% | 0.00% |
| 5 | STATE STREET CORP | 73K | $71K | 0.0% | 0.502% | 0.00% |
| 6 | BlackRock, Inc. | 56K | $55K | 0.0% | 0.390% | 0.00% |
| 7 | NORTHERN TRUST CORP | 32K | $31K | 0.0% | 0.221% | 0.00% |
| 8 | TWO SIGMA SECURITIES, LLC | 21K | $20K | β | 0.145% | 0.00% |
| 9 | DIMENSIONAL FUND ADVISORS LP | 12K | $12K | β | 0.084% | 0.00% |
| 10 | Squarepoint Ops LLC | 11K | $10K | β | 0.073% | 0.00% |
| 11 | Tower Research Capital LLC (TRC) | 5K | $5K | +69.8% | 0.037% | 0.00% |
| 12 | UBS Group AG | 2K | $2K | -31.6% | 0.012% | 0.00% |
| 13 | ROYAL BANK OF CANADA | 17 | $0 | β | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in ABVC β a direct measure of their conviction.
Filings activity in ABVC during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new ABVC position in Q1 2026
Institutions that fully closed their ABVC position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 13 | 13% | 4.52% | 6.23 pp | $1M | 58% |
| Q4 2025 | 15 | +7.1% | 10.75% | 2.86 pp | $2M | 21% |
| Q3 2025 | 14 | +40% | 13.61% | +8.95 pp | $2M | +192% |
| Q2 2025 | 10 | 9.1% | 4.66% | +2.92 pp | $1M | +168% |
| Q1 2025 | 11 | 21% | 1.74% | +0.42 pp | $0M | +31% |
| Q4 2024 | 14 | +40% | 1.32% | +0.43 pp | $0M | +49% |
| Q3 2024 | 10 | 17% | 0.89% | 0.08 pp | $0M | 8.6% |
| Q2 2024 | 12 | β | 0.97% | β | $0M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ABVC stock.
Based on Q1 2026 13F filings, institutional ownership of ABVC BioPharma, Inc. stands at 4.5%, held across 13 reporting institutions.
GEODE CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of ABVC, with approximately 221,169 shares worth $0.00B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of ABVC, including RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA SECURITIES, LLC.
Our composite Smart Money Score for ABVC is 39 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
6 institutions opened new positions in ABVC during Q1 2026, while 8 fully exited. 0 added to existing positions and 7 trimmed.
ABVC institutional ownership fell by 6.23 percentage points quarter-over-quarter, with a net change of -2 holders.
The top 10 institutions account for 99.1% of all reported 13F value in ABVC, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
ABVC BioPharma, Inc. (ABVC) Institutional Ownership